Bicycle Therapeutics plc BCYC

$ 14.05 -3.44%

Quarterly report 2024-Q3
added 10-31-2024

Bicycle Therapeutics plc Income Statement 2011-2024 | BCYC

Annual Income Statement Bicycle Therapeutics plc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	802 M	680 M	1.22 B	513 M	121 M	-	-	-	-	-	-	-	-
Shares	35.6 M	29.7 M	25.1 M	19.1 M	11 M	-	-	-	-	-	-	-	-
Historical Prices	22.5	22.9	48.8	26.8	10.9	-	-	-	-	-	-	-	-
Net Income	-181 M	-113 M	-66.8 M	-51 M	-30.6 M	-21.8 M	-16.3 M	-	-	-	-	-	-
Revenue	27 M	14.5 M	11.7 M	10.4 M	13.8 M	7.14 M	2.06 M	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-190 M	-117 M	-65.6 M	-52 M	-26.3 M	-21.7 M	-16.2 M	-	-	-	-	-	-
Interest Expense	3.26 M	3.34 M	2.98 M	457 K	-5.38 M	-665 K	-119 K	-	-	-	-	-	-
EBITDA	-183 M	-113 M	-64.2 M	-50.7 M	-25.3 M	-21 M	-15.9 M	-	-	-	-	-	-
Operating Expenses	217 M	131 M	77.3 M	62.4 M	40.1 M	28.9 M	18.3 M	-	-	-	-	-	-
General and Administrative Expenses	60.4 M	49.5 M	32.4 M	29.2 M	14.6 M	8.12 M	6.41 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Bicycle Therapeutics plc

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	69 M	52 M	42.6 M	42.4 M	39.6 M	30.2 M	30 M	29.9 M	29.7 M	29.6 M	29.6 M	29.6 M	25 M	24.1 M	22.1 M	21.1 M	19.4 M	18.1 M	18 M	17.9 M	17.9 M	7.3 M	834 K	503 K	434 K	420 K	397 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-50.8 M	-39.8 M	-26.6 M	-	-49.9 M	-42.6 M	-39.1 M	-	-28.3 M	-26.8 M	-27.6 M	-	-14.7 M	-17.9 M	-16.2 M	-17.4 M	-10.1 M	-12.1 M	-11.3 M	-4.41 M	-9.48 M	-10.2 M	-6.5 M	-6.64 M	-7.69 M	-4.98 M	-2.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	2.68 M	9.36 M	19.5 M	-	5.35 M	11.4 M	4.9 M	-	3.04 M	4.38 M	3.86 M	-	4.33 M	1.78 M	1.81 M	3.85 M	3.84 M	1.57 M	1.13 M	5.28 M	614 K	1.52 M	6.38 M	1.06 M	1.61 M	1.66 M	2.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-63.8 M	-46.6 M	-31.7 M	-	-50.8 M	-43.1 M	-41.8 M	-	-29.8 M	-27.3 M	-27.4 M	-	-14.3 M	-17.3 M	-16 M	-	-10.7 M	-12.6 M	-11.6 M	-	-10.3 M	-7.99 M	-3.29 M	-	-6.36 M	-4.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	821 K	-	814 K	821 K	808 K	-	817 K	883 K	818 K	-	823 K	819 K	522 K	-	-	-	-	-	-5.38 M	-2.18 M	-3.19 M	-	-1.36 M	-73 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-61.6 M	-45 M	-30.1 M	-	-49.1 M	-41.5 M	-40.2 M	-	-28.5 M	-26.7 M	-27 M	-	-13.3 M	-17 M	-15.7 M	-	-9.73 M	-12 M	-11.3 M	-	-9.57 M	-7.54 M	-3.08 M	-	-5.83 M	-4.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	66.5 M	56 M	51.2 M	-	56.1 M	54.5 M	46.7 M	-	32.8 M	31.7 M	31.2 M	-	18.6 M	19.1 M	17.8 M	20.9 M	14.5 M	14.2 M	12.8 M	10 M	10.9 M	9.51 M	9.68 M	8.6 M	7.97 M	6.62 M	5.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	18.3 M	15.9 M	16.4 M	-	16.3 M	14.8 M	14.5 M	-	10 M	11.8 M	17 M	-	8.11 M	7.34 M	8.14 M	-	7.15 M	6.2 M	5 M	-	4.79 M	2.97 M	3.4 M	-	2.32 M	1.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency